跳至主要内容
临床试验/IRCT20230223057510N1
IRCT20230223057510N1已完成3 期

The Effect of Astaxanthin Administration on Oxidative Stress Markers and Inflammatory Cytokines in the Follicular Fluid of Patients with Poor Ovarian Response: A Triple-Blind, Randomized control trial

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
36 years 至 41 years(—)
性别
Female

入选标准

  • POR will be diagnosed based on PSEIDON: (i) age > 35 years,
  • (ii) anti-Mullerian hormone (AMH) < 1.2 ng/mL or antral follicle count (AFC) < 5
  • The couple should be a candidate for ICSI

排除标准

  • including spontaneous pregnancy,
  • history of ovarian surgery,
  • autoimmune or endocrine disease (diabetes, thyroid dysfunction, presence of anti-thyroid antibody or polycystic ovary),
  • hyperprolactinemia,
  • severe endometriosis (stages III and IV based on AFS-rAFS classification of endometriosis),
  • recurrent Spontaneous miscarriage,
  • ovarian tumor,
  • chromosomal defect,
  • uterine disorder,
  • more than 3 previous IVF cycles,
  • severe male factor infertility (especially non-obstructive azoospermia),
  • history of taking drugs that affect ovarian function such as steroids and OCP.
  • Also, people who have used antioxidant supplements, vitamins or drugs affecting the hormonal profile 3 months before the start of the plan will not be included in the plan.
  • have any history of male factor infertility.

研究者

相似试验

The Effect of Astaxanthin Administration on poor... | 临床试验